Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 88

1.

Sustained efficacy and seroconversion with the Toll-like receptor 7 agonist GS-9620 in the Woodchuck model of chronic hepatitis B.

Menne S, Tumas DB, Liu KH, Thampi L, AlDeghaither D, Baldwin BH, Bellezza CA, Cote PJ, Zheng J, Halcomb R, Fosdick A, Fletcher SP, Daffis S, Li L, Yue P, Wolfgang GH, Tennant BC.

J Hepatol. 2015 Jun;62(6):1237-45. doi: 10.1016/j.jhep.2014.12.026. Epub 2015 Jan 2.

2.

Identification of an intrahepatic transcriptional signature associated with self-limiting infection in the woodchuck model of hepatitis B.

Fletcher SP, Chin DJ, Cheng DT, Ravindran P, Bitter H, Gruenbaum L, Cote PJ, Ma H, Klumpp K, Menne S.

Hepatology. 2013 Jan;57(1):13-22. doi: 10.1002/hep.25954.

3.

Electroporation enhances immunogenicity of a DNA vaccine expressing woodchuck hepatitis virus surface antigen in woodchucks.

Liu KH, Ascenzi MA, Bellezza CA, Bezuidenhout AJ, Cote PJ, Gonzalez-Aseguinolaza G, Hannaman D, Luxembourg A, Evans CF, Tennant BC, Menne S.

J Virol. 2011 May;85(10):4853-62. doi: 10.1128/JVI.02437-10. Epub 2011 Mar 9.

4.

Glucosidase inhibition enhances presentation of de-N-glycosylated hepatitis B virus epitopes by major histocompatibility complex class I in vitro and in woodchucks.

Norton PA, Menne S, Sinnathamby G, Betesh L, Cote PJ, Philip R, Mehta AS, Tennant BC, Block TM.

Hepatology. 2010 Oct;52(4):1242-50. doi: 10.1002/hep.23806.

5.

Rapid immunity to vaccination with woodchuck hepatitis virus surface antigen using cationic liposome-DNA complexes as adjuvant.

Cote PJ, Butler SD, George AL, Fairman J, Gerin JL, Tennant BC, Menne S.

J Med Virol. 2009 Oct;81(10):1760-72. doi: 10.1002/jmv.21566.

PMID:
19697409
6.

Calculating the return on investment of mobile healthcare.

Oriol NE, Cote PJ, Vavasis AP, Bennet J, Delorenzo D, Blanc P, Kohane I.

BMC Med. 2009 Jun 2;7:27. doi: 10.1186/1741-7015-7-27.

7.

Antiviral effects of lamivudine, emtricitabine, adefovir dipivoxil, and tenofovir disoproxil fumarate administered orally alone and in combination to woodchucks with chronic woodchuck hepatitis virus infection.

Menne S, Butler SD, George AL, Tochkov IA, Zhu Y, Xiong S, Gerin JL, Cote PJ, Tennant BC.

Antimicrob Agents Chemother. 2008 Oct;52(10):3617-32. doi: 10.1128/AAC.00654-08. Epub 2008 Aug 1.

8.

Serologic survey of woodchuck hepatitis virus in North Carolina woodchucks (Marmota monax).

Cullen JM, Lindsey-Pegram D, Cote PJ.

J Zoo Wildl Med. 2008 Jun;39(2):263-5.

PMID:
18634221
9.

Immunogenicity in mice and rabbits of DNA vaccines expressing woodchuck hepatitis virus antigens.

Luxembourg A, Hannaman D, Wills K, Bernard R, Tennant BC, Menne S, Cote PJ.

Vaccine. 2008 Jul 29;26(32):4025-33. doi: 10.1016/j.vaccine.2008.05.021. Epub 2008 Jun 2.

PMID:
18556096
11.

Antiviral effect of orally administered (-)-beta-D-2-aminopurine dioxolane in woodchucks with chronic woodchuck hepatitis virus infection.

Menne S, Asif G, Narayanasamy J, Butler SD, George AL, Hurwitz SJ, Schinazi RF, Chu CK, Cote PJ, Gerin JL, Tennant BC.

Antimicrob Agents Chemother. 2007 Sep;51(9):3177-84. Epub 2007 Jul 2.

12.

Immunosuppression reactivates viral replication long after resolution of woodchuck hepatitis virus infection.

Menne S, Cote PJ, Butler SD, Toshkov IA, Gerin JL, Tennant BC.

Hepatology. 2007 Mar;45(3):614-22.

PMID:
17326155
13.
14.

Clevudine inhibits hepatitis delta virus viremia: a pilot study of chronically infected woodchucks.

Casey J, Cote PJ, Toshkov IA, Chu CK, Gerin JL, Hornbuckle WE, Tennant BC, Korba BE.

Antimicrob Agents Chemother. 2005 Oct;49(10):4396-9.

15.

Antiviral effect of oral administration of tenofovir disoproxil fumarate in woodchucks with chronic woodchuck hepatitis virus infection.

Menne S, Cote PJ, Korba BE, Butler SD, George AL, Tochkov IA, Delaney WE 4th, Xiong S, Gerin JL, Tennant BC.

Antimicrob Agents Chemother. 2005 Jul;49(7):2720-8.

16.

Clevudine therapy with vaccine inhibits progression of chronic hepatitis and delays onset of hepatocellular carcinoma in chronic woodchuck hepatitis virus infection.

Korba BE, Cote PJ, Menne S, Toshkov I, Baldwin BH, Wells FV, Tennant BC, Gerin JL.

Antivir Ther. 2004 Dec;9(6):937-52.

PMID:
15651753
17.

Hepatocellular carcinoma in the woodchuck model of hepatitis B virus infection.

Tennant BC, Toshkov IA, Peek SF, Jacob JR, Menne S, Hornbuckle WE, Schinazi RD, Korba BE, Cote PJ, Gerin JL.

Gastroenterology. 2004 Nov;127(5 Suppl 1):S283-93. Review.

PMID:
15508096
18.

Interferon-gamma-associated responses to woodchuck hepatitis virus infection in neonatal woodchucks and virus-infected hepatocytes.

Wang Y, Jacob JR, Menne S, Bellezza CA, Tennant BC, Gerin JL, Cote PJ.

J Viral Hepat. 2004 Sep;11(5):404-17.

PMID:
15357645
19.

Suppression of lamivudine-resistant B-domain mutants by adefovir dipivoxil in the woodchuck hepatitis virus model.

Jacob JR, Korba BE, Cote PJ, Toshkov I, Delaney WE 4th, Gerin JL, Tennant BC.

Antiviral Res. 2004 Aug;63(2):115-21.

PMID:
15302140
20.

Integration of woodchuck hepatitis and N-myc rearrangement determine size and histologic grade of hepatic tumors.

Jacob JR, Sterczer A, Toshkov IA, Yeager AE, Korba BE, Cote PJ, Buendia MA, Gerin JL, Tennant BC.

Hepatology. 2004 Apr;39(4):1008-16.

PMID:
15057905
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk